Janney Montgomery Scott LLC Decreases Position in Seres Therapeutics, Inc. (NASDAQ:MCRB)
Janney Montgomery Scott LLC decreased its stake in Seres Therapeutics, Inc. (NASDAQ:MCRB – Free Report) by 29.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...
Oncotelic CEO Vuong Trieu to Present Groundbreaking Research on Transforming Growth Factor Beta 2 (TGFB2) at SWCR 2025 Conference
Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...